This site contains promotional information intended only for healthcare professionals resident in the United Kingdom
Sign in
Sign In or Register
Sign out

Information relating to specific disease areas aligned to Pfizer’s portfolio and other resources designed for Pfizer medicines.

See all Therapy areas

Explore Content

The content of this website has been produced in line with the IBRANCE® Summary of Product Characteristics for Great Britain and Northern Ireland. IBRANCE® (palbociclib) Prescribing Information for Great Britain and Northern Ireland click here.  Adverse event reporting information can be found at the bottom of the page.

Models of Care​​​​​​​ in Breast Cancer Services

Pharmacy-led, Breast Cancer Clinic and Cyclical Dispensing

Please find below case study service examples from across the UK. The summary videos and interactive PDFs illustrate how oncology services have adapted in order to manage the increasing demands on capacity1,2 and the growing number of patients living with cancer3. These materials are intended to support Healthcare Professionals with their mBC Services:

Clatterbridge Cancer Centre

​​​​​​​Multi-disciplinary, Nurse-led Breast Cancer Clinic

Clatterbridge Cancer Centre

A case study video and interactive PDF outlining how The Clatterbridge Cancer Centre successfully funded a team of cancer nurse specialists, specifically dedicated to supporting patients with mBC.

Speaker: Jo Francis, mBC Clinical Nurse Specialist, Clatterbridge Cancer Centre, NHSFT

Open Case Study PDF

Hub and Spoke Multidisciplinary Pharmacy led mBC Clinic

Clatterbridge Cancer Centre

A case study video summarising the service challenges and solutions employed at The Clatterbridge Cancer Centre. The service model described here is centrered around a Hub and Spoke Multidisciplinary Pharmacy led mBC clinic.

Speaker: Helen Flint, Consultant Pharmacist, Clatterbridge Cancer Centre, NHSFT

Maidstone and Tunbridge Wells NHST

Multi-disciplinary, Nurse-led Breast Cancer Clinic

Maidstone and Tunbridge Wells NHST

A case study video and interactive PDF highlighting the capacity challenges in mBC care that led to the redesigning of breast cancer services at Maidstone and Tunbridge Wells NHST.

Speaker: Claire Ryan, Macmillan Nurse Consultant, Maidstone and Tunbridge Wells NHST

Open Case Study PDF

Royal Shrewsbury Hospital, Lingen Davies Cancer Centre

​​​​​​​Remote Monitoring Supported by the IBRANCE Dispense and Delivery (IDD) Service

Royal Shrewsbury Hospital, Lingen Davies Cancer Centre

A case study video and interactive PDF explaining how the Lingen Davies Cancer Centre successfully reduced clinic attendance and delivered treatment to patient's homes through the IDD service.

Speaker: Laura Pettit, Consultant Clinical Oncologist, Royal Shrewsbury Hospital

Open Case Study PDF

The Christie NHSFT, Manchester 

Pharmacy-Led NMP Clinics and Treatment Delivery through Ibrance Dispense and Delivery (IDD) Service

The Christie, NHSFT, Manchester

A case study video describing how The Christie Cancer Centre in Manchester successfully set up a pharmacy-led non-medical prescriber (NMP) clinic with cyclical dispensing of CDK 4/6 inhibtors that allowed patients to receive their treatment at home.

Speaker: Ms Suzanne Frank, Advanced Specialist Breast Cancer Pharmacist, The Christie Hospital, Manchester

Airedale Breast Cancer Centre, NHSFT, West Yorkshire

Increasing Breast Cancer Service Capacity with Mobile Cancer Care Units

Airedale Breast Cancer Centre, NHSFT

A case study video explaining how Airedale NHSFT successfully established mobile cancer care units to increase capacity within their breast cancer service.

Speaker: Carl Booth, Consultant Pharmacist, Airedale Breast Cancer Centre, West Yorkshire

Nottingham University Hospitals NHST ​​​​​​​

NMP Pharmacy-Led Oral SACT Clinic in Collaboration with a MDT Mestastatic Breast Cancer Service

Nottingham University Hospitals NHS Trust.

Open Case Study PDF

Royal United Hospital Bath ​​​​​​​

Pharmacist-Led Secondary Breast Cancer Clinic and Monitoring Service

Royal United Hospitals, Bath.​​​​​​​​​​​​​​

Open Case Study PDF

Abbreviations
mBC:
metastatic breast cancer, MDT: multi-disciplinary team, NHSFT: National Health Service Foundation Trust, NHST: National Health Service Trust, NMP: non-medical prescriber, SACT: systemic anti-cancer therapy.
​​​​​​​
References

1. Cancer Research UK. Available at: https://www.cancerresearchuk.org/health-professional/diagnosis/hp-covid-19-and-cancer-hub#HP_COVID-190 [Last accessed April 2022].
2. Cancer services recovery plan. Available at: https://www.england.nhs.uk/coronavirus/wp-content/uploads/sites/52/2020/12/C0821-COVID-19-Cancer-services-recovery-plan-14-December-2020.pdf  [Last accessed April 2022].
3. Maddams J, et al. Br J Cancer 2012;107:1195-202.


PP-IBR-GBR-3945. April 2022

Resources

Resources to assist you and your patients
  • Adapting Breast Cancer Care during COVID-19 Pandemic
  • NMP Service Resources
  • Ibrance® Dispense and Delivery Service​​​​​​​
    ​​​​​​​
    Materials
    ​​​​​​​
    Videos

Indication

  • IBRANCE® is indicated for the treatment of HR+/HER2- locally advanced or metastatic breast cancer:
       - In combination with an aromatase inhibitor; or
    ​​​​​​​   - In combination with fulvestrant in women who have received prior ET

    In pre- or perimenopausal women, the ET should be combined with a LHRH agonist

For UK Healthcare Professionals*

These pages are not intended for patients or for members of the general public. The healthcare professional web pages contain promotional content.

I confirm that I am a healthcare professional* resident in the United Kingdom.

If you select 'No', you will be redirected to Pfizer.co.uk where you will be able to access reference information on Pfizer's prescription medicines.

*The ABPI Code definition for healthcare professional is members of the medical, dental, pharmacy and nursing professionals and any other persons who in the course of their professional activities may administer, prescribe, purchase, recommend or supply a medicine.

PP-PFE-GBR-3863. November 2021

Yes

No

OK, We will need you to sign in before we can determine if you are aligned with a Pfizer promotional colleague.This is an interstitial message to prompt a HCP before they login.

If you have already registered with pfizerpro.co.uk and select ‘yes’, you will be directed to the sign-in page where you will be required to enter your username and password.

Would you like to register or sign in now?